{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:53:01Z","timestamp":1784559181909,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,5]],"date-time":"2012-02-05T00:00:00Z","timestamp":1328400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s11060-012-0802-y","type":"journal-article","created":{"date-parts":[[2012,2,4]],"date-time":"2012-02-04T04:53:31Z","timestamp":1328331211000},"page":"109-114","source":"Crossref","is-referenced-by-count":44,"title":["Seizure prophylaxis and melanoma brain metastases"],"prefix":"10.1007","volume":"108","author":[{"given":"S. A.","family":"Goldlust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Lassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Panageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,5]]},"reference":[{"issue":"14","key":"802_CR1","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system. J Clin Oncol 22(14):2865\u20132872","journal-title":"J Clin Oncol"},{"issue":"8","key":"802_CR2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","volume":"117","author":"MA Davies","year":"2011","unstructured":"Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A (2011) Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117(8):1687\u20131696","journal-title":"Cancer"},{"issue":"4","key":"802_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00165714","volume":"1","author":"TN Byrne","year":"1983","unstructured":"Byrne TN, Cascino TL, Posner JB (1983) Brain metastasis from melanoma. J Neurooncol 1(4):313\u2013317","journal-title":"J Neurooncol"},{"issue":"1","key":"802_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1212\/WNL.40.1.158","volume":"40","author":"NA Hagen","year":"1990","unstructured":"Hagen NA, Cirrincione C, Thaler HT, DeAngelis LM (1990) The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 40(1):158\u2013160","journal-title":"Neurology"},{"issue":"21\u201322","key":"802_CR5","first-page":"911","volume":"114","author":"S Oberndorfer","year":"2002","unstructured":"Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 114(21\u201322):911\u2013916","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"802_CR6","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 54(10):1886\u20131893","journal-title":"Neurology"},{"issue":"1","key":"802_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-009-0056-5","volume":"96","author":"T Mikkelsen","year":"2010","unstructured":"Mikkelsen T, Paleologos NA, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, McDermott M, Mehta MP, Olson JJ, Patchell RA, Ryken TC, Kalkanis SN (2010) The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1):97\u2013102","journal-title":"J Neurooncol"},{"issue":"2","key":"802_CR8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0317167100053361","volume":"30","author":"PA Forsyth","year":"2003","unstructured":"Forsyth PA, Weaver S, Fulton D, Brasher PM, Sutherland G, Stewart D, Hagen NA, Barnes P, Cairncross JG, DeAngelis LM (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30(2):106\u2013112","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"802_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.46.4.985","volume":"46","author":"MJ Glantz","year":"1996","unstructured":"Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46(4):985\u2013991","journal-title":"Neurology"},{"issue":"1\u20132","key":"802_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01420191","volume":"103","author":"S Franceschetti","year":"1990","unstructured":"Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Pluchino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) 103(1\u20132):47\u201351","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"802_CR11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","volume":"58","author":"JB North","year":"1983","unstructured":"North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 58(5):672\u2013677","journal-title":"J Neurosurg"},{"issue":"3","key":"802_CR12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141\u20131154","journal-title":"Ann Stat"},{"issue":"4","key":"802_CR13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","volume":"1","author":"DA Karnofsky","year":"1948","unstructured":"Karnofsky DA, Abelmann WH, Carver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1(4):634\u2013656","journal-title":"Cancer"},{"issue":"9","key":"802_CR14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1528-1157.2003.05203.x","volume":"44","author":"B Schaller","year":"2003","unstructured":"Schaller B, Ruegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44(9):1223\u20131232","journal-title":"Epilepsia"},{"issue":"10","key":"802_CR15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","volume":"47","author":"JB Chalk","year":"1984","unstructured":"Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 47(10):1087\u20131090","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"802_CR16","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.1985.03360150038012","volume":"254","author":"DD Wong","year":"1985","unstructured":"Wong DD, Longenecker RG, Liepman M, Baker S, LaVergne M (1985) Phenytoin-dexamethasone: a possible drug\u2013drug interaction. JAMA 254(15):2062\u20132063","journal-title":"JAMA"},{"issue":"1","key":"802_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1528-1157.1983.tb04868.x","volume":"24","author":"P Bollini","year":"1983","unstructured":"Bollini P, Riva R, Albani F, Ida N, Cacciari L, Bollini C, Baruzzi A (1983) Decreased phenytoin level during antineoplastic therapy: a case report. Epilepsia 24(1):75\u201378","journal-title":"Epilepsia"},{"issue":"7","key":"802_CR18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2(7):404\u2013409","journal-title":"Lancet Neurol"},{"issue":"1","key":"802_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","volume":"10","author":"C Johannessen Landmark","year":"2010","unstructured":"Johannessen Landmark C, Patsalos PN (2010) Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10(1):119\u2013140","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"802_CR20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","volume":"47","author":"S Ramael","year":"2006","unstructured":"Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A (2006) Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47(7):1128\u20131135","journal-title":"Epilepsia"},{"issue":"26","key":"802_CR21","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101(26):9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"802_CR22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4088\/JCP.v65n0901","volume":"65","author":"SM Stahl","year":"2004","unstructured":"Stahl SM (2004) Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator. J Clin Psychiatry 65(9):1162\u20131163","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"802_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78(1):99\u2013102","journal-title":"J Neurooncol"},{"issue":"9","key":"802_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","volume":"71","author":"TA Milligan","year":"2008","unstructured":"Milligan TA, Hurwitz S, Bromfield EB (2008) Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71(9):665\u2013669","journal-title":"Neurology"},{"issue":"8","key":"802_CR25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605622","volume":"102","author":"M Staudt","year":"2010","unstructured":"Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, Tatagiba M, Brossart P, Garbe C (2010) Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 102(8):1213\u20131218","journal-title":"Br J Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-012-0802-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0802-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:17:34Z","timestamp":1559348254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-012-0802-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1007\/s11060-012-0802-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13952959.15408061","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,5]]}}}